BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive: However, cell apoptosis induced by TKI in CML might be not completely depended on BIM pathway and cancer response to TKI in patients with BIM deletion polymorphism might depend on other proapopotic regulators 45, 46.